TLCI yields 0.63% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, TLCI + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLCI + MRK for your $10,000?
TLCI concentrates on large-cap equity securities from non-US companies, applying a bottom-up approach to select 25 to 40 diverse, financially sound businesses. Selection emphasizes high cash returns on tangible capital, strong balance sheets, and management committed to shareholder interests. Up to 10% of assets may be invested in emerging markets, creating an additional growth avenue. The fund avoids specific sector focuses but may emphasize certain sectors for higher potential returns. With a typical holding period of around five years, TCLI aims to minimize transaction costs and taxes. The fund's approach is centered on achieving long-term capital appreciation by investing in undervalued companies with strong growth prospects. Sales occur when overvaluation is detected, fundamentals falter, or better opportunities arise.
Full TLCI Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.